Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Thomas Jefferson University
University of California, San Diego
City of Hope Medical Center
Thomas Jefferson University
City of Hope Medical Center
University of Nebraska
Wake Forest University Health Sciences
University of Nebraska
Kiadis Pharma
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Thomas Jefferson University
University of Rochester
M.D. Anderson Cancer Center
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center